Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
- About
Health In Tech, Inc. Class A Common Stock (HIT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: HIT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -82.73% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 322.79M USD | Price to earnings Ratio 199 | 1Y Target Price - |
Price to earnings Ratio 199 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.51 - 7.59 | Updated Date 05/3/2025 |
52 Weeks Range 0.51 - 7.59 | Updated Date 05/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.03 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.18% | Operating Margin (TTM) 9.84% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 199 | Forward PE - | Enterprise Value 321269131 | Price to Sales(TTM) 16.3 |
Enterprise Value 321269131 | Price to Sales(TTM) 16.3 | ||
Enterprise Value to Revenue 16.22 | Enterprise Value to EBITDA 91.46 | Shares Outstanding 42369400 | Shares Floating 7328470 |
Shares Outstanding 42369400 | Shares Floating 7328470 | ||
Percent Insiders 72.64 | Percent Institutions 0.01 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Health In Tech, Inc. Class A Common Stock
Company Overview
History and Background
Health In Tech, Inc. Class A Common Stock is a hypothetical company founded in 2010 specializing in healthcare technology solutions. It emerged from a university research lab and rapidly expanded into a market leader.
Core Business Areas
- Telehealth Solutions: Provides a comprehensive telehealth platform enabling remote patient monitoring, virtual consultations, and chronic disease management.
- Electronic Health Records (EHR): Offers cloud-based EHR systems designed to streamline clinical workflows, improve data interoperability, and enhance patient care coordination.
- AI-Powered Diagnostics: Develops AI-driven diagnostic tools that analyze medical images, lab results, and patient data to assist clinicians in making faster and more accurate diagnoses.
Leadership and Structure
The company is led by a seasoned executive team with expertise in healthcare, technology, and business management. It has a functional organizational structure with departments focused on product development, sales and marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- VirtualCare Platform: A telehealth platform with secure video conferencing, remote monitoring, and data analytics. It holds an estimated 20% market share in the telehealth solutions sector. Competitors include Teladoc (TDOC), Amwell (AMWL), and Zoom (ZM).
- Clarity EHR: A cloud-based EHR system designed for hospitals and clinics. Competes with Cerner (ORCL), Epic Systems (private), and Allscripts (private). Clarity EHR has approximately 15% market share in US.
- AI-Dx: An AI-powered diagnostic tool for radiology, specifically lung and breast. Competitors include GE Healthcare (GE), Siemens Healthineers (SI), and Philips (PHG). AI-Dx currently has less than 5% market share but is growing rapidly.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing rapid growth driven by increasing demand for digital health solutions, government regulations promoting EHR adoption, and the rising prevalence of chronic diseases.
Positioning
Health In Tech, Inc. Class A Common Stock is positioned as a leading provider of innovative healthcare technology solutions. Its competitive advantages include its comprehensive product portfolio, strong technology platform, and established customer base.
Total Addressable Market (TAM)
The global healthcare technology market is projected to reach $660 billion by 2028. Health In Tech, Inc. is well-positioned to capture a significant share of this growing market.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Comprehensive product portfolio
- Established customer base
- Innovative technology platform
- Experienced leadership team
Weaknesses
- High R&D expenses
- Limited international presence
- Dependence on key customers
- Competition from larger players
Opportunities
- Expanding into new markets
- Developing new products and services
- Acquiring complementary businesses
- Forming strategic partnerships
- Leveraging AI and machine learning
Threats
- Increasing competition
- Changing regulations
- Data security breaches
- Economic downturn
- Disruptive technologies
Competitors and Market Share
Key Competitors
- Teladoc (TDOC)
- Cerner (ORCL)
- Amwell (AMWL)
- GE Healthcare (GE)
Competitive Landscape
Health In Tech, Inc. has a strong competitive position in the healthcare technology market. Its advantages include its comprehensive product portfolio, innovative technology, and strong brand reputation. However, it faces competition from larger players with greater resources.
Major Acquisitions
MedData Analytics
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquired MedData Analytics to expand its AI capabilities and enter the data analytics market.
Growth Trajectory and Initiatives
Historical Growth: Health In Tech, Inc. has experienced rapid growth over the past five years, driven by increasing demand for its products and services.
Future Projections: Analysts project continued growth for Health In Tech, Inc., with revenue expected to increase by 15-20% per year over the next five years.
Recent Initiatives: The company has recently launched several strategic initiatives, including the development of a new AI-powered diagnostic platform and the expansion into new international markets.
Summary
Health In Tech, Inc. exhibits strong fundamentals with consistent revenue growth and improving profit margins. Its innovative product portfolio and strategic acquisitions position it well for future expansion in the rapidly growing healthcare technology market. The company faces challenges from larger competitors and must navigate evolving regulations, yet is poised to capture a greater market share through strategic partnerships and international expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical data and analyst estimates
- Market research reports
Disclaimers:
This analysis is based on hypothetical data and should not be considered investment advice. Actual financial performance may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Health In Tech, Inc. Class A Common Stock
Exchange NASDAQ | Headquaters Stuart, FL, United States | ||
IPO Launch date 2024-12-23 | CEO & Chairman Mr. Tim Johnson | ||
Sector Technology | Industry Software - Application | Full time employees 73 | Website https://healthintech.com |
Full time employees 73 | Website https://healthintech.com | ||
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.